These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24450313)

  • 1. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.
    Goswami ND; Tsalik EL; Naggie S; Miller WC; Horton JR; Pfeiffer CD; Hicks CB
    Trials; 2014 Jan; 15():31. PubMed ID: 24450313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spine device clinical trials: design and sponsorship.
    Cher DJ; Capobianco RA
    Spine J; 2015 May; 15(5):1133-40. PubMed ID: 25637470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry sponsorship and research outcome.
    Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
    Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals.
    Grey P; Grey A; Bolland MJ
    Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
    Roumiantseva D; Carini S; Sim I; Wagner TH
    Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industry sponsorship and positive outcome in vascular and endovascular randomised trials.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Antoniou GA; Torella F
    Vasa; 2017 Jan; 46(1):67-68. PubMed ID: 27889961
    [No Abstract]   [Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sponsorship of oncology clinical trials in the United States according to age of eligibility.
    Neel DV; Shulman DS; Ma C; Bourgeois F; DuBois SG
    Cancer Med; 2020 Jul; 9(13):4495-4500. PubMed ID: 32351000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry sponsorship and selection of comparators in randomized clinical trials.
    Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
    Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis.
    Bero L; Anglemyer A; Vesterinen H; Krauth D
    Environ Int; 2016; 92-93():597-604. PubMed ID: 26694022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
    Zwierzyna M; Davies M; Hingorani AD; Hunter J
    BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
    Rasmussen N; Lee K; Bero L
    Trials; 2009 Dec; 10():116. PubMed ID: 20015404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between sponsorship and failure rate of dental implants: a systematic approach.
    Popelut A; Valet F; Fromentin O; Thomas A; Bouchard P
    PLoS One; 2010 Apr; 5(4):e10274. PubMed ID: 20422000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sponsorship of clinical trials related to the spine: Trends over time and comparative analysis of trial characteristics by sponsorship type.
    Caruana DL; Jiang W; Elaydi A; Grauer JN
    N Am Spine Soc J; 2024 Mar; 17():100296. PubMed ID: 38130466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective outcome reporting and sponsorship in randomized controlled trials in IVF and ICSI.
    Braakhekke M; Scholten I; Mol F; Limpens J; Mol BW; van der Veen F
    Hum Reprod; 2017 Oct; 32(10):2117-2122. PubMed ID: 28938740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes.
    Nkansah N; Nguyen T; Iraninezhad H; Bero L
    Public Health Nutr; 2009 Oct; 12(10):1931-7. PubMed ID: 19254426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.